案例 (CemiplimAb-rwlc 幸存率和流行病学):在先进的基础细胞癌中进行的一项研究
Soo J Park1, David M Ellison2, Ryan Weight3
1Department of Medicine, Division of Hematology and Oncology, University of California San Diego, La Jolla, CA, USA.
Future oncology (London, England)
|January 11, 2025
概括
转移性基底细胞癌 (BCC) 患者在 hedgehog 途径抑制剂 (HHIs) 上进展,他们的选择有限. 该CASE研究评估了该人群中塞米普利马布的有效性和安全性,解决了现实世界的数据缺口.
科学领域:
- 在瘤学瘤学.
- 皮肤病学 皮肤病学
- 免疫治疗是一种免疫疗法.
背景情况:
- 转移性基底细胞癌 (BCC) 呈现出不良预后,治疗选择有限,刺虫途径抑制剂 (HHI) 失效后.
- 关于晚期BCC患者的临床特征,管理和结果的真实数据很少.
研究的目的:
- 描述来自Cemiplimab-rwlc生存和流行病学 (CASE) 研究的局部晚期或转移性BCC患者队列.
- 评估塞米普利马布在那些失败,不耐受或不适合HHI的患者的有效性和安全性.
- 收集关于治疗模式,患者经验,生活质量和生存结果的真实证据.
主要方法:
- 第四期,多中心,前性,非干预性队列研究 (CASE研究).
- 包括具有局部晚期或转移性BCC的患者,先前有HHI暴露或禁忌.
- 评估结果,包括治疗反应,生活质量,安全性和生存率.
主要成果:
- 本部分将详细介绍所述队列的发现,重点关注治疗疗效,安全性概况和患者报告的结果.
- 在难以治疗的BCC群体中分析现实世界治疗模式和疾病进展.
结论:
- 这项CASE研究旨在提供高级BCC患者在HHI治疗后的综合性特征.
- 这项研究预计将填补有关现实世界治疗利用和患者结果的关键知识差距,为未来的临床实践提供信息.
关键词:
基底细胞癌瘤是一种基本细胞癌.这是一种PD-1抑制剂.在Cemiplimab,我们可以看到.临床试验临床试验临床试验临床试验临床试验流行病学流行病学协议 协议 协议 协议 协议幸存者,就是生存者.更多相关视频
07:29Intramucosal Inoculation of Squamous Cell Carcinoma Cells in Mice for Tumor Immune Profiling and Treatment Response Assessment
Published on: April 22, 2019
11.4K
06:46Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery
Published on: September 27, 2024
211
相关概念视频
01:21Cancer Survival Analysis
328
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
328
01:24Kaplan-Meier Approach
90
The Kaplan-Meier estimator is a non-parametric method used to estimate the survival function from time-to-event data. In medical research, it is frequently employed to measure the proportion of patients surviving for a certain period after treatment. This estimator is fundamental in analyzing time-to-event data, making it indispensable in clinical trials, epidemiological studies, and reliability engineering. By estimating survival probabilities, researchers can evaluate treatment effectiveness,...
90
01:30Skin Cancer
3.1K
Skin cancer is a type of cancer that occurs when there is an abnormal growth of skin cells, usually triggered by damage to the DNA within the skin cells. It is primarily caused by exposure to ultraviolet (UV) radiation from the sun or artificial sources like tanning beds. Skin cancer is the most common type of cancer worldwide, and its incidence continues to rise.
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...
3.1K